Welcome to our vignette series: Clinical Type 2 Diabetes ReviewsThis program consists of four vignettes. You may complete as many vignettes as you choose.This program has been accredited for up to 1.0 Mainpro+ Credit and 1.0 MOC1 Credit (0.25 Credits per vignette).
This event is an accredited group learning activity under Section 1 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program. It is approved by the Canadian Society of Endocrinology and Metabolism for a maximum of 1 credit(s).
|David C.W. Lau(MD, PhD, FRCPC)|
David Strain(MB, ChB, BSc (Hons) MD, FRCP)
Deanna Telner(MD, CCFP)
Elizabeth Rosolowsky(MD, MPH, FAAP, FRCPC)
Filip K. Knop(MD, PhD)
Jeffrey Habert(MD, CCFP, FCFP)
John Axler(MD, CCFP, FCFP)
Peter J. Lin(MD, CCFP)
Robyn L. Houlden(MD, FRCPC)
Thomas Round(MBBS, BSc, DRCOG, MRCGP)
Upon completion of this program, participants will be able to:
- Review the key considerations for selecting an antihyperglycemic agent after metformin therapy
- Examine the impact of cardiovascular disease and patient preference on antihyperglycemic agent selection